Screening for Down syndrome based on maternal age or fetal nuchal translucency: A randomized controlled trial in 39 572 pregnancies

Ultrasound in Obstetrics and Gynecology

Volumn 25, Issue 6, 2005, Pages 537-545

  Saltvedt, S ^a   Almstrom H ^b   Kublickas, M ^c   Valentin, L ^d   Bottinga, R ^e   Bui, T H ^c   Cederholm, M ^f   Conner, P ^c   Dannberg, B ^a   Malcus, P ^d   Marsk, A ^b   Grunewald, C ^a  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chromosomal disorder; Down syndrome; Fetal ultrasonography; Genetic screening; Nuchal translucency; Prenatal diagnosis; Ultrasound

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; FETUS MALFORMATION; GESTATIONAL AGE; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; MASS SCREENING; MATERNAL AGE; POLICY; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION;

ADULT; DOWN SYNDROME; FEMALE; HUMANS; KARYOTYPING; MASS SCREENING; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY OUTCOME;

EID: 20644435133     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1002/uog.1917     Document Type: Article

References (18)

1. Hook EB. Rates of chromosome abnormalities at different maternal ages. Obstet Gynecol 1981; 58: 282-285.
2. Ferguson-Smith MA, Yates JR. Maternal age specific rates for chromosome aberrations and factors influencing them: report of a collaborative European study on 52 965 amniocenteses. Prenat Diagn 1984; 4: Spec No.: 5-44.
3. Nicolaides KH, Brizot ML, Snijders RJM. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy. Br J Obstet Gynaecol 1994; 101: 782-786.
4. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352: 343-346.
5. Saltvedt S, Almstrom H, Kublickas M, Reilly M, Valentin L, Grunewald C. Ultrasound dating at 12-14 or 15-20 weeks of gestation? A prospective cross-validation of established dating formulae in a population of in-vitro fertilized pregnancies randomized to early or late dating scan. Ultrasound Obstet Gynecol 2004; 24: 42-50.
6. Georgsson Ohman S, Saltvedt S, Grunewald C, Waldenstrom U. Does fetal screening affect women's worries about the health of their baby? A randomized controlled trial of ultrasound screening for Down syndrome versus routine ultrasound screening. Acta Obstet Gynecol Scand 2004; 83: 634-640.
7. Nicolaides KH, Sebire NJ, Snijders R. The 11-14-Week Scan. London, UK: Parthenon Publishing Group: 1999.
8. Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995; 10: 356-367.
9. Medical Birth Registration in 1996. Stockholm, Sweden: The National Board of Health and Welfare, Centre for Epidemiology, 1996.
10. Malone FD, D'Alton ME. First-trimester sonographic screening for Down syndrome. Obstet Gynecol 2003; 102(5 Pt 1): 1066-1079.
11. Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191: 45-67.
12. Souter VL, Nyberg DA. Sonographic screening for fetal aneuploidy: first trimester. J Ultrasound Med 2001; 20: 775-790.
13. Stubblefield PG, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol 2004; 104: 174-185.
14. Salvesen KA, Oyen L, Schmidt N, Malt UF, Eik-Nes SH. Comparison of long-term psychological responses of women after pregnancy termination due to fetal anomalies and after perinatal loss. Ultrasound Obstet Gynecol 1997; 9: 80-85.
15. Kornman LH, Wortelboer MJ, Beekhuis JR, Morssink LP, Mantingh A. Women's opinions and the implications of first-versus second-trimester screening for fetal Down syndrome. Prenat Diagn 1997; 17: 1011-1018.
16. de Graaf IM, Tijmstra T, Bleker OP, van Lith JM. Womens' preference in Down syndrome screening. Prenat Diagn 2002; 22: 624-629.
17. Mulvey S, Wallace EM. Women's knowledge of and attitudes to first and second trimester screening for Down syndrome. BJOG 2000; 107: 1302-1305.
18. Smith-Bindman R, Chu P, Bacchetti P, Waters JJ, Mutton D, Alberman E. Prenatal screening for Down syndrome in England and Wales and population-based birth outcomes. Am J Obstet Gynecol 2003; 189: 980-985.